Of note, indeed NAFLD patients present a “metabolic inflexibility”, that is, a reduced capacity to switch back from FFA to glucose oxidation, even in the presence of insulin [43,46,97]. Here, INS is linked to metabolic dysfunction-associated steatotic liver disease.